Mouse models orthologous to FGFR3-related skeletal dysplasias

Pediatric Pathology and Molecular Medicine

Volumn 22, Issue 1, 2003, Pages 87-103

  Brodie, Steven G ^a   Deng, Chu Xia ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Achondroplasia; FGFR3; Gene targeting; Hypochondroplasia; Mouse models; Skeletal development; Skeletal dysplasia; Thanatophoric dysplasia

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; PROTEIN TYROSINE KINASE;

ACHONDROPLASIA; ALLELE; ARTICLE; BONE DEVELOPMENT; BONE DYSPLASIA; BONE GROWTH; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; DWARFISM; ENCHONDRAL OSSIFICATION; GENE MUTATION; GENE TARGETING; GENOME; HUMAN; LONG BONE; MISSENSE MUTATION; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; THANATOPHORIC DWARFISM;

ANIMALS; BONE AND BONES; BONE DISEASES, DEVELOPMENTAL; GENE EXPRESSION REGULATION; MICE; MICE, MUTANT STRAINS; MODELS, ANIMAL; MOLECULAR BIOLOGY; MUTATION, MISSENSE; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR;

EID: 0037220136     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/15227950307697     Document Type: Article

References (68)

1. Dreyer SD, Zhou G, Lee B. The long and the short of it: Developmental genetics of the skeletal dysplasias. Clin Genet 1998;54:464-473.
2. Aszodi A, Bateman JF, Gustafsson E, Boot-Handford R, Fassler R. Mammalian skeletogenesis and extracellular matrix: What can we learn from knockout mice? Cell Struct Funct 2000;25:73-84.
3. Boyadijiev SA, Jabs EW. Online Mendelian Inheritance in Man (OMIM) as a knowledgebase for human developmental disorders Clin Genet 2000;57:253-266.
4. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992;59:115-165.
5. Goldfarb M. Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 1996;7:311-325.
6. Johnson DE, Williams LT. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993;60:1-41.
7. Szebenyi G, Fallon JF. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 1999;185:45-106.
8. Martin GR. The roles of FGFs in the early development of vertebrate limbs. Genes Dev 1998;12:1571-1586.
9. Nishimura T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver(l). Biochim Biophys Acta 2000;1492:203-206.
10. Keegan K, Meyer S, Hayman MJ. Structural and biosynthetic characterization of the fibroblast growth factor receptor 3 (FGFR-3) protein. Oncogene 1991;6:2229-2236.
11. Green PJ, Walsh FS, Doherty P. Promiscuity of fibroblast growth factor receptors. Bioessays 1996;18:639-646.
12. Peters KG, Werner S, Chen G, Williams LT. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 1992;114:233-243.
13. Orr-Urtreger A, Givol D, Yayon A, Yarden Y, Lonai P. Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development 1991;113:1419-1434.
14. Yamaguchi TP, Conlon RA, Rossant J. Expression of the fibroblast growth factor receptor FGFR-1/flg during gastrulation and segmentation in the mouse embryo. Dev Biol 1992;152:75-88.
15. Yamada K, Sakaguchi T, Yuguchi T, et al. Blood-borne macromolecule induces FGF receptor gene expression after focal ischemia. Acta Neurochir Suppl (Wien) 1994;60:261-264.
16. Orr-Urtreger A, Bedford MT, Burakova T, et al. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol 1993;158:475-486.
17. Peters K, Ornitz D, Werner S, Williams L. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol 1993;155:423-430.
18. Stark KL, McMahon JA, McMahon AP. FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse. Development 1991;113:641-651.
19. Weinstein M, Xu X, Ohyama K, Deng CX. FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 1998;125:3615-3623.
20. Deng CX, Wynshaw-Boris A, Shen MM, et al. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev 1994;8:3045-3057.
21. Deng C, Bedford M, Li C, et al. Fibroblast growth factor receptor-1 (FGFR-1) is essential for normal neural tube and limb development. Dev Biol 1997;185:42-54.
22. Xu X, Li C, Takahashi K, et al. Murine fibroblast growth factor receptor lalpha isoforms mediate node regression and are essential for posterior mesoderm development. Dev Biol 1999;208:293-306.
23. Yamaguchi TP, Harpal K, Henkemeyer M, Rossant J. fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev 1994;8:3032-3044.
24. Xu X, Weinstein M, Li C, et al. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 1998;125:753-765.
25. Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai P. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci USA 1998;95:5082-5087.
26. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996;84:911-921.
27. Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 1996;12:390-397.
28. Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R. Toward a molecular understanding of skeletal development [comment]. Cell 1995;80:371-378.
29. Karsenty G. Transcriptional regulation of osteoblast differentiation during development [in process citation]. Front Biosci 1998;3:D834-837.
30. Vortkamp A, Lee K, Lanske B, et al. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein Science 1996;273:613-622.
31. Chen L, Adar R, Yang X, et al. Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest 1999;104:1517-1525.
32. Su WC, Kitagawa M, Xue N, et al. Activation of Statl by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 1997;386:288-292.
33. Sahni M, Ambrosetti DC, Mansukhani A, et al. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 1999;13:1361-1366.
34. Li C, Chen L, Iwata T, et al. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum Mol Genet 1999;8:35-44.
35. Rousseau F, Bonaventure J, Legeai-Mallet L, et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994;371:252-254.
36. Rousseau F, Saugier P, Le Merrer M, et al. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nat Genet 1995;10:11-12.
37. Shiang R, Thompson LM, Zhu YZ, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994;78:335-342.
38. Tavormina PL, Rimoin DL, Cohn DH, et al. Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I. Hum Mol Genet 1995;4:2175-2177.
39. Tavormina PL, Shiang R, Thompson LM, et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995;9:321-328.
40. Bellus GA, Hefferon TW, Ortiz de Luna RI, et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet 1995;56:368-373.
41. Cohen MM, Jr. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: Clinically related skeletal dysplasias that are also related at the molecular level. Int J Oral Maxillofac Surg 1998;27:451-455.
42. Shah K, Astley R, Cameron AH. Thanatophoric dwarfism. J Med Genet 1973;10:243-252.
43. Orioli IM, Castilla, EE, Barbosa-Neto JG. The birth prevalence rates for the skeletal dysplasias. J Med Genet 1986;23:328-332.
44. Wilcox WR, Tavormina PL, Krakow D, et al. Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Am J Med Genet 1998;78:274-281.
45. Passos-Bueno MR, Wilcox WR, Jabs EW, et al. Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mut 1999;14:115-125.
46. Avivi A, Yayon A, Givol D. A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III. FEBS Lett 1993;330:249-252.
47. Chellaiah AT, McEwen DG, Werner S, Xu J, Ornitz DM. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J Biol Chem 1994;269:11620-11627.
48. Naski MC, Wang Q, Xu J, Ornitz DM. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet 1996;13:233-237.
49. Webster MK, Donoghue DJ. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. Embo J 1996;15:520-527.
50. Webster MK, D'Avis PY, Robertson SC, Donoghue DJ. Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol Cell Biol 1996;16:4081-4087.
51. Schindler C, Shuai K, Prezioso VR, Darnell JE, Jr. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 1992;257:809-813.
52. Fu XY, Zhang JJ. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell 1993;74:1135-1145.
53. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995;82:675-684.
54. Superti-Furga A, Eich G, Bucher HU, et al. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur J Pediatr 1995;154:215-219.
55. Neilson KM, Friesel RE. Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J Biol Chem 1995;270:26037-26040.
56. Neilson KM, Friesel R. Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J Biol Chem 1996;271:25049-25057.
57. Robertson SC, Meyer AN, Hart KC, et al. Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc Natl Acad Sci USA 1998;95:4567-4572.
58. Galvin BD, Hart KC, Meyer AN, Webster MK. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras. Proc Natl Acad Sci USA 1996;93:7894-7899.
59. Park WJ, Theda C, Maestri NE, et al. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet 1995;57:321-328.
60. Wilkie AO, Morriss-Kay GM, Jones EY, Heath JK. Functions of fibroblast growth factors and their receptors. Curr Biol 1995;5:500-507.
61. Iwata T, Chen L, Li C, et al. A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum Mol Genet 2000;9:1603-1613.
62. Lakso M, Pichel JG, Gorman JR, et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci USA 1996;93:5860-5865.
63. Kaufman MH, Bard JBL. The Anatomical Basis of Mouse Development. San Diego, CA: Academic Press, 1999;93-108.
64. Kaufman RL, Rimoin DL, McAlister WH, Kissane JM. Thanatophoric dwarfism. Am J Dis Child 1970;120:53-57.
65. Powell PP, Wang CC, Horinouchi H, et al. Differential expression of fibroblast growth factor receptors 1 to 4 and ligand genes in late fetal and early postnatal rat lung. Am J Respir Cell Mol Biol 1998;19:563-572.
66. Naski MC, Ornitz DM. FGF signaling in skeletal development [in process citation]. Front Biosci 1998;3:D781-794.
67. Wang Y, Spatz MK, Kannan K, et al. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc Natl Acad Sci USA 1999;96:4455-4460.
68. Monsonego-Ornan E, Adar R, Feferman T, Segev O, Yayon A. The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation. Mol Cell Biol 2000;20:516-522.